Terms: = Ovarian cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
75 results:
1. The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of harmine and their crosstalk.
Zhu J; Zhu H; Zhu Q; Xu SL; Xiao L; Zhang MY; Gao J
Sci Rep; 2024 Mar; 14(1):6504. PubMed ID: 38499622
[TBL] [Abstract] [Full Text] [Related]
2. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
[TBL] [Abstract] [Full Text] [Related]
3. Epigallocatechin gallate inhibits ovarian cancer cell growth and induces cell apoptosis via activation of foxo3A.
Zhang Z; Zhang Q; Yu Y; Su S
In Vitro Cell Dev Biol Anim; 2023 Dec; 59(10):739-746. PubMed ID: 38038884
[TBL] [Abstract] [Full Text] [Related]
4. foxo3 and PTEN expression in the ovary of girls with extra-gonadal cancer with or without chemotherapy treatment prior to cryopreservation.
Albamonte MI; Calabró LY; Albamonte MS; Vitullo AD
BMC Womens Health; 2023 Sep; 23(1):509. PubMed ID: 37737182
[TBL] [Abstract] [Full Text] [Related]
5. PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth.
Chen S; Chen J; Du W; Mickelsen DM; Shi H; Yu H; Kumar S; Yan C
Circ Res; 2023 Jul; 133(2):138-157. PubMed ID: 37232184
[TBL] [Abstract] [Full Text] [Related]
6. Screening and Identification of a Prognostic Model of ovarian cancer by Combination of Transcriptomic and Proteomic Data.
Jiang J; Chen Z; Wang H; Wang Y; Zheng J; Guo Y; Jiang Y; Mo Z
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189432
[TBL] [Abstract] [Full Text] [Related]
7. Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human ovarian cancer and by Regulation of the IL-6/STAT3/foxo3a Pathway.
Park SA; Seo YJ; Kim LK; Kim HJ; Yoon KD; Heo TH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047012
[No Abstract] [Full Text] [Related]
8. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma.
Lee YM; Chen YH; Ou DL; Hsu CL; Liu JH; Ko JY; Hu MC; Tan CT
J Pathol; 2023 Apr; 259(4):428-440. PubMed ID: 36641765
[TBL] [Abstract] [Full Text] [Related]
9. Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers.
Lan H; Yuan J; Zhang R; Jiang B; Li Q; Huang Z; Chen P; Xiang H; Zeng X; Xiao S
Genomics; 2023 Mar; 115(2):110554. PubMed ID: 36587749
[TBL] [Abstract] [Full Text] [Related]
10. Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression.
Feng J; Ma WW; Li HX; Pei XY; Deng SL; Jia H; Ma WZ
Front Endocrinol (Lausanne); 2022; 13():895095. PubMed ID: 35992124
[TBL] [Abstract] [Full Text] [Related]
11. An
Lee CM; Kang MA; Bae JS; Park K; Yang YH; Lee J; Jang KY; Park SH
Hum Exp Toxicol; 2022; 41():9603271221089257. PubMed ID: 35417658
[TBL] [Abstract] [Full Text] [Related]
12.
Shen L; Lee S; Joo JC; Hong E; Cui ZY; Jo E; Park SJ; Jang HJ
J Microbiol Biotechnol; 2022 Apr; 32(4):493-503. PubMed ID: 35283423
[TBL] [Abstract] [Full Text] [Related]
13. Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium.
van der Ploeg P; Uittenboogaard A; Bosch SL; van Diest PJ; Wesseling-Rozendaal YJW; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ
Gynecol Oncol; 2022 Apr; 165(1):114-120. PubMed ID: 35123772
[TBL] [Abstract] [Full Text] [Related]
14. Aulosirazoles B and C from the Cyanobacterium
Davis LJ; Maldonado AC; Khin M; Krunic A; Burdette JE; Orjala J
J Nat Prod; 2022 Mar; 85(3):540-546. PubMed ID: 35100504
[TBL] [Abstract] [Full Text] [Related]
15. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract] [Full Text] [Related]
16. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of foxo3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract] [Full Text] [Related]
17. Circular RNA foxo3 enhances progression of ovarian carcinoma cells.
Wang L; Chen J; Lu C
Aging (Albany NY); 2021 Sep; 13(18):22432-22443. PubMed ID: 34555810
[TBL] [Abstract] [Full Text] [Related]
18. LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/foxo3/BID axis to inhibit the progression of pancreatic cancer.
Bi C; Wang G
J Cell Mol Med; 2021 Sep; 25(17):8312-8328. PubMed ID: 34363438
[TBL] [Abstract] [Full Text] [Related]
19. Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.
Takahashi A; Yousif A; Hong L; Chefetz I
J Mol Med (Berl); 2021 May; 99(5):637-650. PubMed ID: 33641066
[TBL] [Abstract] [Full Text] [Related]
20. Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/foxo3 pathway.
Huo Q; Xu C; Shao Y; Yu Q; Huang L; Liu Y; Bao H
Int J Biol Sci; 2021; 17(2):574-588. PubMed ID: 33613114
[No Abstract] [Full Text] [Related]
[Next]
